Mechanomind

Applying Computer Vision and Deep Learning to solve the problem of accessibility, accuracy, speed and cost of cancer diagnostics worldwide. Derm AI tool provides 99% accuracy across common diagnoses including melanoma (significantly better than an average accuracy of board certified pathologists), validated by an independent lab at the University of Chicago Medicine. Scanner neutral, effectively copes with slides quality variability. Our solution can be deployed both locally at the laborato[1][2]

2015 Founded2 People on the graph

Overview

Mechanomind is a company operating in the New York artificial intelligence scene[1] that applies computer vision and deep learning to cancer diagnostics[2]. The company operates in the biotechnology industry[3]. Mechanomind's dermatology AI tool achieves 99% accuracy across common diagnoses including melanoma, with results validated by an independent laboratory at the University of Chicago Medicine[2]. The tool functions across different scanner types and handles variability in slide quality[2]. The company's diagnostic solution can be deployed locally at laboratory facilities[2]. Mechanomind was founded in 2015[2] and operates with a team of four employees[3].

Business address: Broad Street, New York, New York. [6]

Growth & traction

LinkedIn lists 4 people working at Mechanomind. [4]

Key people

Alumni

Something wrong or missing? Send an update. Fixed within 24 hours.